Therapeutic effects of hypercapnia on chronic lung injury and vascular remodeling in neonatal rats

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 297, Issue 5, 2009, Pages

  Masood, Azhar ^a,d   Yi, Man ^a,d   Lau, Mandy ^a,d   Belcastro, Rosetta ^a   Shek, Samuel ^a   Pan, Jingyi ^a   Kantores, Crystal ^b   McNamara, Patrick J ^a,c   Kavanagh, Brian P ^a,c,d   Belik, Jaques ^a,c,d   Jankov, Robert P ^b,c,d   Tanswell, A Keith ^a,c,d  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b Canada   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Carbon dioxide; Inflammation; Lung growth

Indexed keywords

ANGIOPOIETIN 1; PEROXYNITRITE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL WALL THICKENING; ARTERY MEDIA; ARTICLE; BODY WEIGHT; CARBON DIOXIDE BREATHING; CHRONIC LUNG DISEASE; CONTROLLED STUDY; LUNG ALVEOLUS MACROPHAGE; LUNG BLOOD VESSEL; LUNG INJURY; LUNG PARENCHYMA; LUNG WEIGHT; NEUTROPHIL COUNT; NEWBORN; NITRATION; NONHUMAN; OXYGEN BREATHING; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; THERAPEUTIC HYPERCAPNIA;

ACTINS; AIR; ANIMALS; ANIMALS, NEWBORN; BLOOD GAS ANALYSIS; BLOOD VESSELS; CARBON DIOXIDE; ELASTIN; FLUORESCENT ANTIBODY TECHNIQUE; HEART RATE; HYPERCAPNIA; LUNG; LUNG INJURY; NEUTROPHILS; ORGAN SIZE; PEROXIDASE; RATS; SUBCELLULAR FRACTIONS; TYROSINE; VON WILLEBRAND FACTOR;

EID: 72449141022     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00139.2009     Document Type: Article

References (54)

1. Amato MD, Barbas CS, Medeiros DM, Magaldi RB, Schettino GP, Lorenzi-Fihlo G, Kairalla RA, Deheinzelin D, Munoz C, Oliveira R, Takagaki TY, Carvalho CR. Effects of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 338: 347-354, 1998. (Pubitemid 28083906)
2. Auten RL Jr, Mason SN, Tanaka DT, Welty-Wolf K, Whorton MH. Anti-neutrophil chemokines preserve alveolar development in hyperoxia-exposed newborn rats. Am J Physiol Lung Cell Mol Physiol 281: L336-L344, 2001. (Pubitemid 32756045)
3. Bancalari E, Abdenour GE, Feler R, Gannon J. Bronchopulmonary dysplasia: clinical presentation. J Pediatr 95: 819-823, 1979.
4. Bancalari E, Wilson-Costello D, Iben SC. Management of infants with bronchopulmonary dysplasia in North America. Early Hum Dev 81: 171-179, 2005. (Pubitemid 40320907)
5. Belik J, Jankov RP, Pan J, Tanswell AK. Peroxynitrite inhibits relaxation and induces pulmonary artery muscle contraction in the newborn rat. Free Radic Biol Med 37: 1384-1392, 2004. (Pubitemid 39359158)
6. Bidani A, Tzouanakis AE, Cardenas VJ Jr, Zwischenberger JB. Permissive hypercapnia in acute respiratory failure. JAMA 272: 957-962, 1994. (Pubitemid 24288551)
7. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
8. Buch S, Han RN, Cabacungan J, Wang JX, Yuan SZ, Belcastro R, Deimling J, Jankov R, Luo XP, Lye SJ, Post M, Tanswell AK. Changes in expression of platelet-derived growth factor and its receptors in the lungs of newborn rats exposed to air or 60% O2. Pediatr Res 48: 423-433, 2000. (Pubitemid 30729069)
9. Carlo WA, Stark AR, Wright LL, Tyson JE, Papile LA, Shankaran S, Donovan EF, Oh W, Bauer CR, Saha S, Poole WK, Stoll B. Minimal ventilation to prevent bronchopulmonary dysplasia in extremely-lowbirth- weight infants. J Pediatr 141: 370-374, 2002.
10. Coalson JJ. Pathology of chronic lung disease of early infancy. In: Chronic Lung Disease in Early Infancy, edited by Bland RD and Coalson JJ. New York: Dekker, 1999, p. 85-124.
11. Dunnill MS. Quantitative methods in the study of pulmonary pathology. Thorax 17: 320-328, 1962.
12. Fabres J, Carlo WA, Phillips V, Howard G, Ambalavanan N. Both extremes of arterial carbon dioxide pressure and the magnitude of fluctuations in arterial carbon dioxide pressure are associated with severe intraventricular hemorrhage in preterm infants. Pediatrics 119: 299-305, 2007. (Pubitemid 46397754)
13. Frid MG, Brunetti JA, Burke DL, Carpenter TC, Davie NJ, Reeves JT, Roedersheimer MT, van Rooijen N, Stenmark KR. Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage. Am J Pathol 168: 659-669, 2006.
14. Gow A, Duran D, Thom SR, Ischiropoulos H. Carbon dioxide enhancement of peroxynitrite-mediated protein tyrosine nitration. Arch Biochem Biophys 333: 42-48, 1996. (Pubitemid 26276972)
15. Han RN, Buch S, Tseu I, Young J, Christie NA, Frndova H, Lye SJ, Post M, Tanswell AK. Changes in structure, mechanics and insulin-like growth factor-related gene expression in the lungs of newborn rats exposed to air or 60% O2. Pediatr Res 39: 921-929, 1996. (Pubitemid 26170968)
16. Hickling KG, Walsh J, Henderson S, Jackson R. Low mortality rate in adult respiratory distress syndrome using low-volume, pressure-limited ventilation with permissive hypercapnia: a prospective study. Crit Care Med 22: 1568-1578, 1994. (Pubitemid 24320879)
17. Holmes JM, Zhang S, Leske DA, Lanier WL. Carbon dioxide-induced retinopathy in the neonatal rat. Curr Eye Res 17: 608-616, 1998. (Pubitemid 28288659)
18. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29: 577-580, 1981. (Pubitemid 11147380)
19. 2-mediated pulmonary hypertension in neonatal rats: a role for products of lipid peroxidation. Pediatr Res 48: 289-298, 2000.
20. 2-induced pulmonary hypertension in the neonatal rat. Pediatr Res 50: 172-183, 2001.
21. Jankov RP, Belcastro R, Ovcina E, Lee J, Massaeli H, Lye SJ, Tanswell AK. Thromboxane A2 receptors mediate pulmonary hypertension in 60% oxygen-exposed newborn rats by a cyclooxygenase-independent mechanism. Am J Respir Crit Care Med 166: 208-214, 2002. (Pubitemid 34765458)
22. Jankov RP, Luo X, Demin P, Aslam R, Hannan V, Tanswell AK, Pace-Asciak CR. Hepoxilin analogs inhibit bleomycin-induced pulmonary fibrosis in the mouse. J Pharmacol Exp Ther 301: 435-440, 2002. (Pubitemid 34429952)
23. Jankov RP, Johnstone L, Luo X, Robinson BH, Tanswell AK. Macrophages as a major source of oxygen radicals in the hyperoxic newborn rat lung. Free Radic Biol Med 35: 200-209, 2003. (Pubitemid 36835920)
24. Jankov RP, Kantores C, Belcastro R, Yi M, Tanswell AK. Endothelin- 1 inhibits apoptosis of pulmonary arterial smooth muscle in the neonatal rat. Pediatr Res 60: 245-251, 2006. (Pubitemid 44267733)
25. Jankov RP, Tanswell AK. Hypercapnia and the neonate. Acta Paediatr 97: 1502-1509, 2008.
26. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163: 1723-1729, 2001.
27. Kawakami M, Paul JL, Thurlbeck WM. The effect of age on lung structure in male BALB/cNNia inbred mice. Am J Anat 170: 1-21, 1984. (Pubitemid 14101470)
28. 1- Antitrypsin protects neonatal rats from pulmonary vascular and parenchymal effects of oxygen toxicity. Pediatr Res 36: 763-770, 1994.
29. Kregenow DA, Swenson ER. The lung and carbon dioxide: implications for permissive and therapeutic hypercapnia. Eur Respir J 20: 6-11, 2002.
30. Kregenow DA, Rubenfeld GD, Hudson LD, Senson ER. Hypercapnic acidosis and mortality in acute lung injury. Crit Care Med 34: 229-231, 2006.
31. Laffey JG, Kavanagh BP. Carbon dioxide and the critically ill - too little of a good thing? Lancet 354: 1283-1286, 1999.
32. Laffey JG, Tanaka M, Engelberts D, Luo X, Yuan S, Tanswell AK, Post M, Lindsay T, Kavanagh BP. Therapeutic hypercapnia reduces pulmonary and systemic injury following in vivo lung reperfusion. Am J Respir Crit Care Med 162: 2287-2294, 2000. (Pubitemid 32051702)
33. Laffey JG, O'Coinin D, McLoughlin P, Kavanagh BP. Permissive hypercapnia - role in protective lung ventilatory strategies. Intensive Care Med 30: 347-356, 2004. (Pubitemid 38375607)
34. Li G, Zhou D, Vicencio AG, Ryu J, Xue J, Kanaan A, Gavrialov O, Haddad GG. Effect of carbon dioxide on neonatal mouse lung: a genomic approach. J Appl Physiol 101: 1056-1564, 2006.
35. Mariani G, Cifuentes J, Carlo WA. Randomized trial of permissive hypercapnia in preterm infants. Pediatrics 104: 1082-1088, 1999. (Pubitemid 29529183)
36. Matthay MA, Bhattacharya S, Gaver D, Ware LB, Lim LH, Syrkina O, Eyal F, Hubmayr R. Ventilator-induced lung injury: in vivo and in vitro mechanisms. Am J Physiol Lung Cell Mol Physiol 283: L678-L682, 2002. (Pubitemid 35052661)
37. Mazzeo AT, Spada A, Pratico C, Lucanto T, Santamaria LB. Hypercapnia: what is the limit in paediatric patients? A case of near-fatal asthma successfully treated by multipharmacological approach. Paediatr Anaesth 14: 596-603, 2004. (Pubitemid 38869929)
38. McComb RD, Jones TR, Pizzo SV, Bigner DD. Specificity and sensitivity of immunohistochemical detection of factor VIII/von Willebrand factor antigen in formalin-fixed paraffin-embedded tissue. J Histochem Cytochem 30: 371-377, 1988.
39. Ni Chonghaile M, Higgins BD, Costello JF, Laffey JG. Hypercapnic acidosis attenuates severe acute bacterial pneumonia-induced lung injury by a neutrophil-independent mechanism. Crit Care Med 36: 3135-3144, 2008.
40. Obrosova IG, Mabley JG, Zsengellér Z, Charniauskaya T, Abatan OI, Groves JT, Szabó C. Role for nitrosative stress in diabetic neuropathy: evidence from studies with a peroxynitrite decomposition catalyst. FASEB J 19: 401-403, 2005. (Pubitemid 40316530)
41. Padela S, Cabacungan J, Shek S, Belcastro R, Yi M, Jankov RP, Tanswell AK. Hepatocyte growth factor is required for alveologenesis in the neonatal rat. Am J Respir Crit Care Med 172: 907-914, 2005. (Pubitemid 41369076)
42. Pierce MR, Bancalari E. The role of inflammation in the pathogenesis of bronchopulmonary dysplasia. Pediatr Pulmonol 19: 371-378, 1995.
43. Schittny JC, Mund SI, Stampanoni M. Evidence and structural mechanism for late lung alveolarization. Am J Physiol Lung Cell Mol Physiol 294: L246-L254, 2008. (Pubitemid 351253361)
44. Sinclair SE, Kregenow DA, Lamm WJ, Starr IR, Chi EY, Hlastala MP. Hypercapnic acidosis is protective in an in vivo model of ventilator-induced lung injury. Am J Respir Crit Care Med 166: 403-408, 2002. (Pubitemid 34864435)
45. 2 on ventilated preterm lamb lungs. Pediatr Res 53: 468-472, 2003.
46. Subhedar NV, Hamdan AH, Ryan SW, Shaw NJ. Pulmonary artery pressure: early predictor of chronic lung disease in preterm infants. Arch Dis Child 78: F20-F24, 1998. (Pubitemid 28241975)
47. Thibeault DW, Truog WE, Ekekezie II. Acinar arterial changes with chronic lung disease of prematurity in the surfactant era. Pediatr Pulmonol 36: 482-489, 2003.
48. 2 targets during the first seven days of life. Biol Neonate 90: 218-225, 2006.
49. Urwin L, Murphy R, Robertson C, Pollok A. A case of extreme hypercapnia: implications for the prehospital and accident and emergency department management of acutely dyspnoeic patients. Emerg Med J 21: 119-120, 2004. (Pubitemid 38165507)
50. Varughese M, Patole S, Shama A, Whitehall J. Permissive hypercapnia in neonates: the case of the good, the bad, and the ugly. Pediatr Pulmonol 33: 56-64, 2002. (Pubitemid 34031555)
51. Vozzelli MA, Mason SN, Whorton MH, Auten RL Jr. Antimacrophage chemokine treatment prevents neutrophil and macrophage influx in hyperoxia- exposed newborn rat lung. Am J Physiol Lung Cell Mol Physiol 286: L488-L493, 2004.
52. Weibel ER, Gomez DM. A principle for counting tissue structures on random sections. J Appl Physiol 17: 343-348, 1962.
53. Yi M, Jankov RP, Belcastro R, Humes D, Copland I, Shek S, Sweezey NB, Post M, Albertine KH, Auten RL, Tanswell AK. Opposing effects of 60% oxygen and neutrophil influx on alveologenesis in the neonatal rat. Am J Respir Crit Care Med 170: 1188-1196, 2004. (Pubitemid 39577377)
54. Yi M, Belcastro R, Shek S, Luo D, Post M, Tanswell AK. Fibroblast growth factor-2 and receptor-1α(IIIc) regulate postnatal rat lung cell apoptosis. Am J Respir Crit Care Med 174: 581-589, 2006. (Pubitemid 44330552)